NDC 51655-196 – Ondansetron

Ondansetron 8 mg/1 · Tablet, Orally Disintegrating · Oral

Human Prescription Drug

Product NDC51655-196

Product details

Brand name
Ondansetron
Generic name
Ondansetron
Labeler
Northwind Health Company, LLC
Dosage form
Tablet, Orally Disintegrating
Route
Oral
Marketing category
ANDA · ANDA090469
Marketed since
July 20, 2022
Listing expires
December 31, 2027
Pharmacologic class
Serotonin-3 Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Ondansetron →

Package NDC codes (4)

Package NDCDescriptionSince
51655-196-044 TABLET, ORALLY DISINTEGRATING in 1 BAG (51655-196-04)Apr 27, 2023
51655-196-5310 TABLET, ORALLY DISINTEGRATING in 1 BAG (51655-196-53)Jul 20, 2022
51655-196-808 TABLET, ORALLY DISINTEGRATING in 1 BAG (51655-196-80)Jul 20, 2022
51655-196-876 TABLET, ORALLY DISINTEGRATING in 1 BAG (51655-196-87)Mar 13, 2023

Other Ondansetron products